Cargando…

The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly

Anticoagulation is superior to dual antiplatelet therapy (DAPT) in the prevention of thromboembolic events in patients with atrial fibrillation (AF), otherwise the prevention of ischemic risk and stent thrombosis after percutaneous coronary intervention (PCI) is warranted by DAPT. The coexistence of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bencivenga, Leonardo, Komici, Klara, Corbi, Graziamaria, Cittadini, Antonio, Ferrara, Nicola, Rengo, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046549/ https://www.ncbi.nlm.nih.gov/pubmed/30038586 http://dx.doi.org/10.3389/fphys.2018.00876

Ejemplares similares

Cardioprotective Effects of Dietary Phytochemicals on Oxidative Stress in Heart Failure by a Sex-Gender-Oriented Point of View
por: Komici, Klara, et al.
Publicado: (2020)

β-adrenergic receptor responsiveness in aging heart and clinical implications
por: Ferrara, Nicola, et al.
Publicado: (2014)

Pressure injuries in elderly with acute myocardial infarction
por: Komici, Klara, et al.
Publicado: (2017)

Inter-relationships between Gender, Frailty and 10-Year Survival in Older Italian Adults: an observational longitudinal study
por: Corbi, Graziamaria, et al.
Publicado: (2019)

Impact of Malnutrition on Long-Term Mortality in Elderly Patients with Acute Myocardial Infarction
por: Komici, Klara, et al.
Publicado: (2019)

Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
por: Femminella, Grazia Daniela, et al.
Publicado: (2018)

Editorial: Post COVID-19 physical performance and functional capacity
por: Komici, Klara, et al.
Publicado: (2022)

microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases
por: de Lucia, Claudio, et al.
Publicado: (2017)

Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives
por: Femminella, Grazia Daniela, et al.
Publicado: (2017)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
por: Cannavo, Alessandro, et al.
Publicado: (2017)

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019)

Ventilatory efficiency in post‐COVID‐19 athletes
por: Komici, Klara, et al.
Publicado: (2023)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: De Luca, Leonardo, et al.
Publicado: (2022)

Endothelial Progenitor Cells and Rheumatoid Arthritis: Response to Endothelial Dysfunction and Clinical Evidences
por: Komici, Klara, et al.
Publicado: (2021)

Impact of Galectin-3 Circulating Levels on Frailty in Elderly Patients with Systolic Heart Failure
por: Komici, Klara, et al.
Publicado: (2020)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
por: Koziński, Marek, et al.
Publicado: (2020)

Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Liang, Bo, et al.
Publicado: (2022)

Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)

Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
por: Jacobs, M. S., et al.
Publicado: (2018)

Adrenergic signaling and oxidative stress: a role for sirtuins?
por: Corbi, Graziamaria, et al.
Publicado: (2013)

Muscle Ultrasound as Imaging Domain of Frailty
por: Bencivenga, Leonardo, et al.
Publicado: (2022)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
por: de Veer, A. J. W. M., et al.
Publicado: (2020)

Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada
por: Eberhardt, Theresa E., et al.
Publicado: (2021)

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
por: Zhao, Shujuan, et al.
Publicado: (2021)

The WOEST 2 registry: A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
por: de Veer, A. J. W. M., et al.
Publicado: (2022)

Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in Japan
por: Nakano, Yasuhiro, et al.
Publicado: (2023)

Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
por: Liccardo, Daniela, et al.
Publicado: (2020)

Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?
por: Leggio, Massimo, et al.
Publicado: (2018)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
por: Fan, Yongqiang, et al.
Publicado: (2022)

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention
por: Poirier, Caylie M., et al.
Publicado: (2023)

Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis
por: Gong, Xiaoxuan, et al.
Publicado: (2017)

Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?
por: Bencivenga, Leonardo, et al.
Publicado: (2021)

Adiponectin and Sarcopenia: A Systematic Review With Meta-Analysis
por: Komici, Klara, et al.
Publicado: (2021)

Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants
por: Goette, Andreas, et al.
Publicado: (2020)

Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: A meta-analysis
por: Moustafa, Abdelmoniem, et al.
Publicado: (2020)

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Kwon, Soonil, et al.
Publicado: (2021)

COVID-19 and the elderly: insights into pathogenesis and clinical decision-making
por: Perrotta, Fabio, et al.
Publicado: (2020)

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2020)

Correction to: COVID-19 and the elderly patients: insights into pathogenesis and clinical decision-making
por: Perrotta, Fabio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ap7cn6rh3o4njaif8r3lk1fce2